Novo Nordisk A/S

NVO

$35.29

Name : Novo Nordisk A/S

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $157,858,086,912.00

EPSttm : 3.56

Novo Nordisk A/S

$35.29

1.51%

$0.525

NVO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.73

Margin Of Safety %

Put/Call OI Ratio

0.77

EPS Next Q Diff

4.09

EPS Last/This Y

17.56

EPS This/Next Y

0.41

Price

36.03

Target Price

47.71

Analyst Recom

2.56

Performance Q

-31.43

Upside

25.2%

Beta

0.75

Ticker: NVO

14 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-03	NVO	36.66	0.72	0.77	1568494
2026-03-04	NVO	38.45	0.72	0.50	1617740
2026-03-06	NVO	38.6	0.72	0.47	1684708
2026-03-09	NVO	39.82	0.73	0.25	1621827
2026-03-10	NVO	38.72	0.72	0.36	1637122
2026-03-11	NVO	38.85	0.72	0.46	1662327
2026-03-12	NVO	38.03	0.72	1.44	1677403
2026-03-13	NVO	38.02	0.72	1.92	1677403
2026-03-17	NVO	38.44	0.72	0.60	1666581
2026-03-18	NVO	37.47	0.72	0.63	1676885
2026-03-20	NVO	36.49	0.71	0.68	1717087
2026-03-25	NVO	36.35	0.76	1.60	1521307
2026-03-26	NVO	36.4	0.78	0.42	1548195
2026-03-27	NVO	36.07	0.77	0.59	1594485
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

14 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	NVO	37.75	-24.4	-1627.7	21.05
2026-03-03	NVO	36.70	-24.4	-2372.3	21.05
2026-03-04	NVO	38.44	-24.4	-1105.7	21.05
2026-03-05	NVO	39.06	0.6	-1871.2	21.05
2026-03-06	NVO	38.58	0.6	-2339.9	21.05
2026-03-09	NVO	39.81	0.6	-1903.2	21.05
2026-03-10	NVO	38.75	0.6	-2728.2	21.05
2026-03-11	NVO	38.85	0.6	-2164.7	21.05
2026-03-12	NVO	38.03	0.6	-2729.5	21.05
2026-03-13	NVO	37.98	0.6	-2535.4	21.05
2026-03-17	NVO	38.44	0.6	-2361.5	21.05
2026-03-18	NVO	37.49	0.6	-3113.7	21.05
2026-03-19	NVO	37.07	0.6	-2780.1	21.05
2026-03-20	NVO	36.53	0.6	-2774.0	21.05
2026-03-23	NVO	36.83	0.6	-2601.1	21.05
2026-03-24	NVO	36.89	0.6	-2575.7	21.21
2026-03-25	NVO	36.34	0.6	-2696.7	21.21
2026-03-26	NVO	36.38	0.6	-2479.4	21.21
2026-03-27	NVO	36.03	0.6	-2834.9	21.21
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	NVO	0.00	-0.41	0.80
2026-03-03	NVO	0.00	-0.41	0.80
2026-03-04	NVO	0.00	-0.41	0.80
2026-03-05	NVO	0.00	-0.41	0.80
2026-03-06	NVO	0.00	-0.41	0.80
2026-03-09	NVO	0.00	-0.40	0.80
2026-03-10	NVO	0.00	-0.40	0.80
2026-03-11	NVO	0.00	-0.40	0.84
2026-03-12	NVO	0.00	-0.40	0.84
2026-03-13	NVO	0.00	-0.40	0.84
2026-03-17	NVO	0.00	-0.32	0.84
2026-03-18	NVO	0.00	-0.32	0.84
2026-03-19	NVO	0.00	-0.32	0.84
2026-03-20	NVO	0.00	-0.32	0.84
2026-03-23	NVO	0.00	0.03	0.84
2026-03-24	NVO	0.00	0.03	0.84
2026-03-25	NVO	0.00	0.03	0.73
2026-03-26	NVO	0.00	0.03	0.73
2026-03-27	NVO	0.00	0.03	0.73
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

6.57

Avg. EPS Est. Next Quarter

5.09

Insider Transactions

Institutional Transactions

0.03

Beta

0.75

Average Sales Estimate Current Quarter

74710

Average Sales Estimate Next Quarter

71628

Fair Value

44.85

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

75.7

Max Drawdown 5-Year %

-75.3

Target Price

47.71

P/E

10.39

Forward P/E

10.84

PEG

P/S

2.6

P/B

5.25

P/Free Cash Flow

13.57

EPS

3.47

Average EPS Est. Cur. Y

21.21

EPS Next Y. (Est.)

21.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

33.03

Relative Volume

0.61

Return on Equity vs Sector %

25.4

Return on Equity vs Industry %

16.1

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.08

EBIT Estimation

-2834.9

◆ NVO Healthcare

$36.04

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

23/25

Volume

9/15

Valuation

18/20

TP/AR

1/10

Options

3/10

RSI

30.2

Range 1M

4.5%

Sup Dist

0.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

8/30

Estimates

8/20

Inst/Vol

2/15

Options

7/10

EPS Yr

-11.4%

EPS NY

3.1%

52W%

0.4%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +353.8% upside

Quality

30/30

Valuation

23/30

Growth

9/25

Stability

4/10

LT Trend

4/5

Upside

+353.8%

Quality

MoS

24%

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 68794

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NVO

Latest News

—

Caricamento notizie per NVO…

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y